Skip to main content
DMAAU logo

DMAAU · Drugs Made In America Acquisition Corp. · Shareholders & Ownership

Track DMAAU — free
$11.00 -0.01 (-0.09%) At close · Oct 27
Market Cap
$264.13M
Shares
24.28M
Volume · Oct 27 209 Avg daily vol (8 sessions) 806

Every disclosed holder of DMAAU in one list: 13F institutions, Schedule 13D and 13G filers, insiders (Forms 3, 4 and 5) and registered funds, each from its own latest filing. Holders nest by CIK and SEC reporting links, never by name, and each is summed once.

Who Owns DMAAU

13F quarter Jun 30, 2026; this listing alone: insiders and shares outstanding are issuer-wide, so they are left out

No chart: shares outstanding cannot be set against these holders.

Holder group Shares % Out
Institutional (13F) 11,530 —
Insiders (Forms 3, 4, 5) 0 —
13D/G-only blocks 0 —
Registered funds (N-PORT, not summed) 0 —

% Out is unavailable: shares outstanding is an issuer-wide count, not one listing's.

13D/G-only counts each filer's latest 13D or 13G that no 13F report of the listing contains, that names no 13F filer and that no counted insider files. Funds are never summed: their shares sit inside their advisers' 13F reports.

Holders of DMAAU

# Holder Shares
1
Clear Street Group Inc.
13F CIK 1881567 · Unknown · Jun 30, 2026
10,005
2
UBS Group AG
13F CIK 1610520 · Bank · Jun 30, 2026
1,525

Shares are restated onto today's split basis. Change compares each row with the same holder's previous filing in the same source; a dash means there is none to compare. Nested 13D/G, insider and fund rows are not summed, since a 13F report already holds them.

Key facts CIK 2028614 CUSIP G2847J104